Dr. Barry Kreiswirth, Professor at the Center for Discovery and Innovation, will give us a talk. This will be an in-person meeting, and lunch will be provided.
Title: The molecular epidemiology of TB: lessons learned and neglected
Speaker: Dr. Barry Kreiswirth, Professor at the Center for Discovery and Innovation
Time: 12pm - 1pm (EST)
Place: Weill Cornell Belfer Research Buidling BB-1101
Dr. Max O'Donnell and Dr. Barun Mathema will host a Symposium on Emerging Resistance to New Anti-Tuberculosis Agents on March 20th-21st to bring together a diverse set of experts to define challenges and identify cross-sector recommendations to address emerging resistance to novel anti-TB agents.
Our faculty member, Dr. Katey Walsh will join the symposium as a speaker.
Dr. Vincent Escuyer, Director of the Mycobacteriology Laboratory at New York State Department of Health will give us a talk. This will be an in-person meeting, and lunch will be provided.
Title: The changing landscape of TB treatment: New challenges for the clinical laboratories
Speaker: Dr. Vincent Escuyer, Director of the Mycobacteriology Laboratory at New York State Department of Health
Time: 12pm - 1pm (EST)
Place: Weill Cornell Belfer Research Buidling BB-1101
Dr. Jyoti Mathad, Associate Professor of Medicine will give a talk about tuberculosis in pregnancy. This will be an in-person meeting, and lunch will be provided.
Title: "Into the unknown: Tuberculosis in Prengnancy"
Speaker: Dr. Jyoti Mathad, Associate Professor of Medicine, Weill Cornell Medicine
Time: 12pm - 1pm (EST)
Place: Weill Cornell Belfer Research Buidling BB-1101
We are having a TB clinical case conference with the NYC Department of Health on Tuesday January 30th at 2pm, at Belfer BB 302-A. The Assistant Commissioner of the NYC Department of Health, Dr. Joseph Burzynski and the city’s TB clinicians will join in person. Dr. Burzynski will give his update on the epidemiology of TB in NYC 2024. Dr. Jyoti Mathad (Adult Medicine) and Dr. Melanie Dubois (Pediatrics) will then discuss a clinical case of TB in a pregnant woman and her infant.
Time: Tuesday January 30th at 2pm- 3:15 pm
Place: The Belfer Research Building, Room BB 302-A
This will be an in-person meeting.
Dr. Christopher Cooper, Senior Director of Chemistry at TB Alliance, will give a talk about TB drug development. This will be an in-person meeting, and lunch will be provided.
Title: "Optimizing a TB-active Lead into a Preclinical Drug Candidate"
Speaker: Dr. Christopher Cooper, Senior Director of Chemistry at TB Alliance
Time: 12pm - 1pm (EST)
Place: Weill Cornell Belfer Research Buidling BB-1101
Monthly journal club to read articles on clinical TB trials is organized by the investogators in NYC TRAC. In today's journal club, Dr. Christopher Brown will lead the discussion on the article, "Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial" by Scriba et al.
Monthly journal club to read articles on clinical TB trials is organized by the investogators in NYC TRAC. In today's journal club, Dr. Daniel Fitzgerald will lead the discussion on the article, "Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis" by Dorman et al.
Next journal club will be on Nvember 29th, 2023 at Belfer Building Room B-1122.
Dr. Kathryn Dupnik, Assistant Professor of Medicine in Infectious Diseases, who has been studing differential human immune responses to the mycobacterial pathogens, M. tuberculosis and M. leprae, will present "What can M. leprae teach us about M. tuberculosis?"
